Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin.

Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It

Health Teva, Allergan, CVS and Walgreens say enough states have agreed to finalize the deal, pouring…

World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen

Markets Heard on the Street As AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be…

World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen

Markets Heard on the Street As AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be…

Teva Tries to Put an End to the Opioid Wars

Wall Street hates long and messy litigation fights. For Teva Pharmaceutical Industries accused of pushing opioid…

Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion

Updated July 26, 2022 8:46 pm ET Listen to article (2 minutes) Teva Pharmaceutical Industries Ltd.…